JPRN-jRCTs031190201已完成3 期
Efficacy of a Moisturizing Cream in the Treatment of Atopic Dermatitis in Preschool Children Study
Katsunuma Toshio0 个研究点目标入组 86 人开始时间: 2020年2月5日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 1age old 至 < 6age old(—)
- 性别
- All
入选标准
- •Patients who meet all of the following criteria are included in this study:
- •1) Patients aged 1 years or older, and younger than 6 years at giving their consent, and who are diagnosed as atopic dermatitis based on the Guidelines of care for management of atopic dermatitis (2018) by the Japanese Dermatological Association
- •2) Patients whose EASI score is 7.1 or higher at acute period, and whose EASI score is diagnosed as less than 7 at the consent after treatment for 2 weeks or longer. Provided that the EASI score is determined by expert physician of allergic diseases.
- •3) Patients whose regal representative gives their consent to participate in the study in a written form.
排除标准
- •Patients who fall into any of the following criteria are excluded from participating in the study:
- •1) Patients who need oral antihistamine or antibacterial agent continuously for 8 days or longer. Patients who can withdraw them during the pre-treatment period can be included in this study.
- •2) Patients who need systemic steroid administration, topical tacrolimus ointment, oral cyclosporine administration, ultraviolet therapy, allergen-specific immunotherapy (sublingual, subcutaneous, or oral), or moisturizing agents other than study products. Patients who can withdraw them during the pre-treatment period can be included in this study.
- •3) Patients who have possibility to start food allergen removal newly during the study.
- •4) Patients who have chronic dermatoses other than atopic dermatitis
- •5) Patients who have allergy to topical steroid
- •6) Patients with other conditions that investigator thinks unsuitable for participating in the study
研究者
相似试验
尚未招募
2 期
Evaluating effectiveness of the moisturizing cream produced by Behpad Teb CompanySkin dryness.IRCT20190210042676N28Iranian Behpad Teb Company20
尚未招募
3 期
Evaluation of the effectiveness of Raphanus sativus in melasmaIRCT20220223054106N1Tehran University of Medical Sciences25
已完成
不适用
Evaluation of the efficacy of a skin moisturizer on mild to moderate atopic dermatitisAtopic dermatitisJPRN-UMIN000030829INFORWARD inc.30
已完成
不适用
The efficacy and safety of new moisturizing cream for dry skin condition and itch reliefDry skin condition in healthy volunteersSkin and Connective Tissue DiseasesISRCTN46216631Korea Health Industry Development Institute (KHIDI) (South Korea)66
招募中
3 期
Effect of Chelidonium majus and hyoscyamus niger with propolis on psoriasisIRCT20200516047462N4Kashan University of Medical Sciences88
